We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Study Demonstrates Radiation Risk from Digital Screening Mammography Can Be Reduced Further

By HospiMedica International staff writers
Posted on 19 Jan 2016
The risk of radiation-induced breast cancer for women undergoing digital screening mammography can be reduced even more for most women by employing simple changes in screening guidelines.

The findings were published in the January 2016, issue of the Annals of Internal Medicine. The research was part of a comprehensive modeling study, undertaken by the UC Davis School of Medicine (Sacramento, CA, USA) that found minimal risk of radiation-induced breast cancer for most women from digital mammography breast cancer screening. More...
Women with large breasts or those with breast implants, often receive extra screening, and have increased radiation exposure. Larger detectors and other new technologies can help mitigate the risk for these women.

The researchers modeled the risk of women developing radiation-induced breast cancer during their lifetime from digital screening mammography, and as a result dying from the disease. The researchers compared this to the number of breast cancer deaths that were prevented by early detection and found that screening 100,000 women aged between 50 and 74, every two years, prevented 627 deaths. The radiation from such exams, and subsequent additional diagnostics, could cause 27 cases of breast cancer, and four deaths. When women aged 40 to 74 were screened every year, an additional 100 radiation-induced breast cancers occurred, and 12 breast cancer deaths, compared to women aged 50 to 74, who were screened every two years.

The results of the study showed screening mammograms taken every two years, instead of yearly, and starting from age 50, not 40 or 45, would be safer for all women.

Diana Miglioretti, first author of the study, and Biostatistics professor at UC Davis School of Medicine, said, “For most women, the risks are very low. The one group I worry about is women with very large breasts who choose to be screened annually from ages 40 to 74. Most screening mammograms are two views per breast. Some women with large breasts need more than four views for a complete screening examination, increasing their exposure to ionizing radiation. In addition, the dose per view increases with compressed breast thickness, further increasing exposure. For the average woman, having an additional workup for an abnormal screening result offers very small additional radiation exposure. But for some women who have additional mammography views and an image-guided biopsy, the additional workup can account for a quarter of their annual radiation exposure from mammography. For the majority of women, screening mammography is very safe. And if you screen every other year between 50 and 74, that makes it safest.”

Related Links:

UC Davis School of Medicine



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Wound Irrigation Solution
Prontosan®
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.